Authors: Parhiz H, Brenner JS, Patel PN, Papp TE, Li Q, Shi R PMID: 34953981 PMCID: PMC8695324 DOI: 10.1016/j.jconrel.2021.12.027 Abstract Current nucleoside-modified RNA lipid nanoparticle (modmRNA-LNP) technology has successfully paved the way for the highest clinical efficacy data from next-generation vaccinations against SARS-CoV-2 during the COVID-19 pandemic. However, such modmRNA-LNP technology has not been characterized [...]